Allergy Therapeutics has announced the appointment of Nick Wykeman (exSkyepharma) to the Board as Finance Director with immediate effect. We view today’s appointment as a solid fit, filling the position that has been open since the announcement earlier this year, with an individual whose life sciences and wider background aligns well with the Allergy business.
